Comparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx
NCT ID: NCT00713674
Last Updated: 2017-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2008-03-31
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Two Protocols for Corporal Decolonization in Patients Colonized by Methicillin Resistant Staphylococcus Aureus (MRSA)
NCT01400308
MRSA Eradication and Decolonization in Children
NCT02127658
Individualized vs. Household MRSA Decolonization
NCT01814371
Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization
NCT00856089
Impact of Mupirocin Decolonization on the Nasal Microbiome
NCT02045329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
No Treatment
No interventions assigned to this group
2
Theraworx intranasal
Theraworx
Theraworx swab intranasal BID for 5 days
3
mupirocin antibiotic ointment intranasal
mupirocin antibiotic ointment
mupirocin antibiotic ointment swab intranasal BID for 5 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Theraworx
Theraworx swab intranasal BID for 5 days
mupirocin antibiotic ointment
mupirocin antibiotic ointment swab intranasal BID for 5 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with MRSA infected wounds
* Patients under the age of 18 years
* A woman currently pregnant or nursing a child
* Patients participating in another study within 30 days of randomization
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mercy Research
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roger E Huckfeldt, MD
Role: PRINCIPAL_INVESTIGATOR
Mercy/St. John's Hospital - Springfield
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SJMRSA-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.